These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24045028)

  • 21. Ring Chromosome 10 in a Case of Acute Promyelocytic Leukemia.
    Shehzad S; Nadeem M; Shan S; Shamsi TS
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):941-942. PubMed ID: 27981936
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia.
    Walter RB; Othus M; Paietta EM; Racevskis J; Fernandez HF; Lee JW; Sun Z; Tallman MS; Patel J; Gönen M; Abdel-Wahab O; Levine RL; Estey EH
    Leukemia; 2015 Oct; 29(10):2104-7. PubMed ID: 25772026
    [No Abstract]   [Full Text] [Related]  

  • 23. Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia.
    Santamaría C; Chillón MC; Fernández C; Martín-Jiménez P; Balanzategui A; García Sanz R; San Miguel JF; González MG
    Haematologica; 2007 Mar; 92(3):315-22. PubMed ID: 17339180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts.
    Ono T; Takeshita A; Kishimoto Y; Kiyoi H; Okada M; Yamauchi T; Emi N; Horikawa K; Matsuda M; Shinagawa K; Monma F; Ohtake S; Nakaseko C; Takahashi M; Kimura Y; Iwanaga M; Asou N; Naoe T;
    Cancer Sci; 2014 Jan; 105(1):97-104. PubMed ID: 24206578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.
    Zhang X; Pan J
    Ann Hematol; 2017 Apr; 96(4):707-708. PubMed ID: 28154895
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment for acute promyelocytic leukemia].
    Fujita H
    Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continued complete remission after a PML/RAR-alpha+ autograft in acute promyelocytic leukaemia.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A
    Eur J Haematol; 1996 Mar; 56(3):186-7. PubMed ID: 8598242
    [No Abstract]   [Full Text] [Related]  

  • 30. A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.
    Torrebadell M; Díaz-Beyá M; Kalko SG; Pratcorona M; Nomdedeu J; Navarro A; Gel B; Brunet S; Sierra J; Camós M; Esteve J
    Leuk Lymphoma; 2018 Oct; 59(10):2394-2404. PubMed ID: 29390924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
    Lu J; Jiang H; Jiang Q; Bao L; Lu XJ; Zhang Y; Lin W; Liu YR; Huang XJ; Jiang B
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2254-7. PubMed ID: 19087672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia.
    Renneville A; Attias P; Thomas X; Bally C; Hayette S; Farhat H; Eclache V; Marceau-Renaut A; Cassinat B; Feuillard J; Terré C; Delabesse E; Park S; Lejeune J; Chevret S; Adès L; Preudhomme C; Fenaux P
    Leukemia; 2018 Sep; 32(9):2066-2069. PubMed ID: 29740159
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of relapsed acute promyelocytic leukemia with gemtuzumab ozogamicin and all-trans retinoic acid.
    Tageja N; Valent J; Zonder J
    J Chemother; 2009 Dec; 21(6):705-6. PubMed ID: 20071299
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of elderly adults with acute promyelocytic leukemia: put the pedal to metal.
    Tallman MS
    Leuk Lymphoma; 2009 Jan; 50(1):12-3. PubMed ID: 19172497
    [No Abstract]   [Full Text] [Related]  

  • 35. [The biological characteristics and treatment of acute promyelocytic leukemia].
    Savchenko VG; Parovichnikova EN; Isaev VG; Demidova IA; Kuliev RG; Gribanova EO; Kliasova GA; Kucher RA; Sokolov AN; Momotiuk KS; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Budianskiĭ VM; Belousov EA; Lapin VA; Voloshin SV; Konstaninova TS; Filatov LB; Porokhina ON; Smirnova EA
    Ter Arkh; 1998; 70(7):5-11. PubMed ID: 9742627
    [No Abstract]   [Full Text] [Related]  

  • 36. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
    Hecht A; Doll S; Altmann H; Nowak D; Lengfelder E; Röllig C; Ehninger G; Spiekermann K; Hiddemann W; Weiß C; Hofmann WK; Nolte F; Platzbecker U
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):889-896.e5. PubMed ID: 28923666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case.
    Specchia G; Storlazzi CT; Cuneo A; Surace C; Mestice A; Pannunzio A; Rocchi M; Liso V
    Ann Hematol; 2001 Apr; 80(4):246-50. PubMed ID: 11401094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How should we prevent hematologic relapse of acute promyelocytic leukemia?
    Nagai S; Takahashi T; Kurokawa M
    J Clin Oncol; 2010 Feb; 28(4):e62; author reply e63-4. PubMed ID: 19841316
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene.
    Meloni G; Diverio D; Vignetti M; Avvisati G; Capria S; Petti MC; Mandelli F; Lo Coco F
    Blood; 1997 Aug; 90(3):1321-5. PubMed ID: 9242568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Characterization and Treatment of Pancreatic Neuroendocrine Tumors.
    De Jesus-Acosta AMC
    Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.